SCHEMBL3757640

SCHEMBL3757640

O=C(O)c1ccc(-c2ccccn2)nc1Oc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
ALDH1A1 P00352 2/20 0.48
MAPT P10636 2/20 0.48
POLB P06746 1/20 0.48
TDP1 Q9NUW8 3/20 0.46
LMNA P02545 3/20 0.45
L3MBTL1 Q9Y468 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
KDM4E B2RXH2 2/20 0.44
F10 P00742 1/20 0.44
KDM6B O15054 1/20 0.44
KDM4A O75164 1/20 0.44
KDM5C P41229 1/20 0.44
KDM4C Q9H3R0 1/20 0.44
KDM2A Q9Y2K7 1/20 0.44
KDM3A Q9Y4C1 1/20 0.44
PDE10A Q9Y233 2/20 0.44
TP53 P04637 1/20 0.43
ALPL P05186 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL861902 0.77 TDP1 (0.71) MEN1KMT2AALDH1A1MAPTPOLB
SCHEMBL70363 0.76 LMNA (0.54) MEN1KMT2AALDH1A1POLBTDP1
SCHEMBL11553992 0.74 MEN1 (0.54) MEN1KMT2AALDH1A1POLBTDP1
Diphenylether SCHEMBL28242094 0.74 KDM4E (0.67) ALDH1A1MAPTPOLBTDP1LMNA
SCHEMBL3341388 0.73 KDM4C (0.50) MEN1KMT2ALMNAL3MBTL1SMN1; SMN2
SCHEMBL3757644 0.71 TDP1 (0.46) MEN1KMT2AALDH1A1MAPTPOLB
SCHEMBL6795380 0.71 ALDH1A1 (0.52) ALDH1A1POLBTDP1LMNAL3MBTL1
Dipyridyl SCHEMBL18601618 0.70 KDM4E (0.74) KMT2AALDH1A1MAPTPOLBTDP1
Dipyridyl SCHEMBL2792069 0.70 KDM4E (0.74) KMT2AALDH1A1MAPTPOLBTDP1
Dipyridyl SCHEMBL30976994 0.70 KDM4E (0.74) KMT2AALDH1A1MAPTPOLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-11-25 US disclosed
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF NAPRT, PNPO, FABP3 MEN1 4297/4885KMT2A 1678/4885ALDH1A1 1855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.